Scientists will use collaborative research and new techniques to explore these understudied areas of DNA in a bid to develop further the understanding of human genetic disease.
Since the human genome was first sequenced in 2003, research has mainly focused on parts of DNA that contain instructions for making proteins – the fundamental building blocks of all organisms.
However, these account for only 2% of the three billion letters that make up the human genome.
The MRC funding, which represents a significant investment in UK genomics research, will enable scientists to focus on the remaining parts of DNA.
Professor Wendy Bickmore, director of the MRC Human Genetics Unit at the University of Edinburgh, said: “It’s exciting that we now have so much human genome sequence data, but we need to turn that data into knowledge about how our genome works in health and disease.
“This new funding will enable us to tackle that challenge together, harnessing experimental and computational expertise to better understand, manage and treat disease and, ultimately, improve the lives of people living with genetic conditions and cancers.”